Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies

  1. Meca-Lallana, J.
  2. García-Merino, J.A.
  3. Martínez-Yélamos, S.
  4. Vidal-Jordana, A.
  5. Costa, L.
  6. Eichau, S.
  7. Rovira, A.
  8. Brieva, L.
  9. Agüera, E.
  10. Zarranz, A.R.-A.
Journal:
Neurodegenerative Disease Management

ISSN: 1758-2032 1758-2024

Year of publication: 2021

Volume: 11

Issue: 3

Pages: 251-261

Type: Review

DOI: 10.2217/NMT-2020-0049 GOOGLE SCHOLAR

Sustainable development goals